Together with previous reports of UCA1 upregulation in liver and pancreatic cancers [39,40] as well as CEBPA-AS1 in liver cancer [41], our results suggest that these plasma RNAs can be universal tumour markers for the diagnosis of gastrointestinal cancers. Here, CEBPA is linked to pancreatic neoplasm.